Perception of Advanced Rehabilitation Technologies Among Post-Stroke Patients and Rehabilitation Staff
ConditionPost Stroke
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHospices Civils de Lyon
About this trial
This observational study aims to assess the perception of advanced rehabilitation technologies among three key groups involved in stroke recovery: post-stroke patients, physicians specialized in Physical and Rehabilitation Medicine, and allied health professionals. The study is conducted at HCL - Renée Sabran Hospital , specifically within the Kermes 2 department. Participants are selected using a non-probability sampling method, based on predefined inclusion and exclusion criteria. Data will be collected using a structured, author-developed questionnaire designed to evaluate attitudes, perceived usefulness, ease of use, and intention to adopt technologies such as exoskeletons, social robots, wearable interactive devices, and biofeedback systems. The questionnaire is applied at a single time point after obtaining informed consent. This research responds to the growing integration of technology in neurorehabilitation and seeks to identify potential barriers or facilitators to its adoption in clinical practice.
The hypothesis is that there is a significant difference in perception and acceptance of advanced rehabilitation technologies between the three groups, influenced by their respective roles, experience, and level of exposure to such technologies.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients: Patients diagnosed with stroke, whether or not they have benefited from advanced rehabilitation technologies.
Physicians: Physicians specialized in Physical and Rehabilitation Medicine who manage patients with stroke.
Allied health professionals: Physiotherapists, psychologists, occupational therapists, speech therapists, neuropsychologists, and psychomotor therapists involved in the rehabilitation of post-stroke patients.
Disqualifiers
Refusal to participate in the study.
Patients who do not wish to benefit from advanced rehabilitation technology.
Healthcare professionals with no experience using advanced rehabilitation technologies.
Trial population
Participants will be recruited from HCL - Renée Sabran Hospital, located in the PACA region (Provence-Alpes-Côte d'Azur), specifically from the Kermes 2 department, as well as through professional medical networks. The study population includes three main groups: (1) patients with a confirmed diagnosis of stroke, whether or not they have been exposed to advanced rehabilitation technologies; (2) physicians specialized in Physical and Rehabilitation Medicine involved in stroke management; and (3) allied health professionals (e.g., physiotherapists, psychologists, occupational therapists, speech therapists, neuropsychologists, psychomotor therapists) actively working in post-stroke rehabilitation settings. Recruitment will focus on individuals affiliated with institutions offering neurological rehabilitation services.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
completion of a structured questionnaire
Other interventioncompletion of a structured questionnaire
Treatment groups
80 Participants
are divided into 3 treatment groupsGroup A: Post-stroke patients1 intervention
Group B: Physicians in Physical and Rehabilitation Medicine1 intervention
Group C: Allied health professionals1 intervention
Trial outcomes
Primary outcomes
1
Perceptions of post-stroke patients, physical medicine and rehabilitation physicians and auxiliary medical staff on Advanced Rehabilitation Technologies.
The primary outcome measure evaluates the perception of advanced rehabilitation technologies among key stakeholders involved in post-stroke recovery. This perception is assessed using a structured questionnaire specifically developed by the authors, designed to capture attitudes, perceived usefulness, ease of use, and intention to adopt technologies such as exoskeletons, social robots, wearable interactive devices, and biofeedback systems. The instrument is applied to three target groups: post-stroke patients, physicians specializing in physical and rehabilitation medicine, and allied health professionals. This measure provides critical insights into the acceptability and potential integration of advanced technologies in neurorehabilitation practice.
Time frame
Day 1Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov